ArticleJournal of cancer research and clinical oncology2012

Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.

Bénédicte Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.